Account
dentsu X India wins media mandate for MyGlamm
Mumbai: dentsu X, the media agency from the house of dentsu India, has won the integrated media mandate for a beauty product company, MyGlamm.
As per the mandate, dentsu X will contribute to the e-commerce enterprise’s expansion plans by designing and deploying an omnichannel media strategy.
Commenting on the win, MyGlamm chief marketing officer Apratim Majumder said, “dentsu X was highly recommended to us, and to our delight, in a very short period, we have discovered exactly why! Their strategic thinking, experience, speed-to-market products, and efficiencies have completely impressed us. Partnering with them on our go-to-market strategy is reassuring, given their data-driven clear-thinking and inventive approach in meeting consumer and company goals.”
dentsu Media South Asia CEO and dentsu X India CEO, Divya Karani added, “We obsess over driving value and delivering the committed outcomes to all our clients’ businesses. Recognition and acknowledgment for our services are invaluable! We are delighted to partner with MyGlamm and move from pillar to strength.”
dentsu X India COO, Roopam Garg commented, “We are honoured to partner with MyGlamm and look forward to deftly navigate the e-commerce opportunities and possibilities that lie ahead.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
